[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @ValueForAll1 value value posts on X about $cdxs, $irwd, $lly, $bmy the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1373080695728398339/interactions)  - X Week XXXXX +52% - X Month XXXXXX +45% - X Months XXXXXX -XX% - X Year XXXXXXX +161% ### Mentions: X [#](/creator/twitter::1373080695728398339/posts_active)  - X Week XX +56% - X Month XX +50% - X Months XX -XX% - X Year XXX +113% ### Followers: XXX [#](/creator/twitter::1373080695728398339/followers)  - X Week XXX +1% - X Month XXX +0.84% - X Months XXX +21% - X Year XXX -XXXX% ### CreatorRank: undefined [#](/creator/twitter::1373080695728398339/influencer_rank)  ### Social Influence [#](/creator/twitter::1373080695728398339/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% [finance](/list/finance) XXXX% [countries](/list/countries) XXXX% **Social topic influence** [$cdxs](/topic/$cdxs) #1, [$irwd](/topic/$irwd) #2, [$lly](/topic/$lly) #115, [$bmy](/topic/$bmy) 2.04%, [$15b](/topic/$15b) 2.04%, [$prqr](/topic/$prqr) 2.04%, [$acet](/topic/$acet) 2.04%, [$fate](/topic/$fate) 2.04%, [$ipsc](/topic/$ipsc) 2.04%, [$abbv](/topic/$abbv) XXXX% **Top accounts mentioned or mentioned by** [@jfais20](/creator/undefined) [@biohazard3737](/creator/undefined) [@biochemyst1](/creator/undefined) [@richtrades100](/creator/undefined) [@sagimet](/creator/undefined) [@immunitybio](/creator/undefined) [@beonemedicines](/creator/undefined) [@iovancebio](/creator/undefined) [@bristolmyers](/creator/undefined) [@jazzpharma](/creator/undefined) [@servierpharma](/creator/undefined) [@genetech](/creator/undefined) [@shikhajainmd](/creator/undefined) [@dredkim](/creator/undefined) [@pikacapital](/creator/undefined) [@oneiltrader](/creator/undefined) [@bigpharmaguy](/creator/undefined) [@sanctuarybio](/creator/undefined) [@krtlarson](/creator/undefined) [@anonym64382296](/creator/undefined) **Top assets mentioned** [Eli Lilly and Company (LLY)](/topic/$lly) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [AbbVie Inc (ABBV)](/topic/$abbv) [Amicus Therapeutics, Inc (FOLD)](/topic/$fold) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Novartis AG (NVS)](/topic/$nvs) ### Top Social Posts [#](/creator/twitter::1373080695728398339/posts) --- Top posts by engagements in the last XX hours "$cdxs focus with ligation is on after phase X or earlier clinical assets with full enzymatic - on preclinical ones. Some people still say they will produce inclisiran for NVS. Nonsense. NVS and ALNY secured their current siRNA manufacturing needs already" [X Link](https://x.com/ValueForAll1/status/1974477908040392879) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-04T14:13Z XXX followers, XXX engagements "If $bmy picks up preclinical Orbital for $1.5B in cash I don't see why $lly has to pay less for $prqr. Novel modalities should be valued appropriately" [X Link](https://x.com/ValueForAll1/status/1977038093523075377) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-11T15:46Z XXX followers, XXX engagements "$cdxs Finally waking up a bit. TIDES EU is in a month this webinar with Bachem looks interesting. Bachem is a one stop to $lly who are betting a lot on oligos for the upcoming decade" [X Link](https://x.com/ValueForAll1/status/1975408139643330975) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-07T03:49Z XXX followers, 1192 engagements "$acet data this week is another signal that CAR-T in I&I is not if but when. Safety will be important of course. But COGS and manufacturing time will be super important. $fate and $ipsc are the best equipped to win on COGS. Fate is on a run Century is a sleeper" [X Link](https://x.com/ValueForAll1/status/1976038179527602487) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-08T21:33Z XXX followers, XXX engagements "$irwd Very likely it's the last month below $X. ACG presentations Abbvie Q3 earnings. Maybe something bigger" [X Link](https://x.com/ValueForAll1/status/1976040355175989392) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-08T21:41Z XXX followers, XXX engagements "$bcrx deal reminds me a bit of $irwd buy of VectivBio. Bet on phase X asset but no CVR used all upfront. And fat debt to finance all that. This ended up badly for $irwd. Not sure how this plays out for BCRX. I prefer $fold approach - pay a small option fee for flipping ph3 card" [X Link](https://x.com/ValueForAll1/status/1978063789254754647) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-14T11:42Z XXX followers, 2365 engagements "As of today the vast majority of building blocks (NQP) for siRNA drugs of e.g. $alny and $nvs is manufactured using hash chemicals with a lot of toxic waste primary in China and India. There should be a better way rooting for $cdxs" [X Link](https://x.com/ValueForAll1/status/1972086600210493741) [@ValueForAll1](/creator/x/ValueForAll1) 2025-09-27T23:50Z XXX followers, XXX engagements "$irwd touched SMA200 today for the first time since forever" [X Link](https://x.com/ValueForAll1/status/1973801826748453179) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-02T17:26Z XXX followers, 1176 engagements "$tecx On April X 2025 Mcguire (BoD chair) sold 500k shares at $XXXX. The same day GOAT Timothy Springer bought 500k shares at $17.1" [X Link](https://x.com/ValueForAll1/status/1978459002947166516) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-15T13:52Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@ValueForAll1 value
value posts on X about $cdxs, $irwd, $lly, $bmy the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXXXX +52%
- X Month XXXXXX +45%
- X Months XXXXXX -XX%
- X Year XXXXXXX +161%
Mentions: X #
- X Week XX +56%
- X Month XX +50%
- X Months XX -XX%
- X Year XXX +113%
Followers: XXX #
- X Week XXX +1%
- X Month XXX +0.84%
- X Months XXX +21%
- X Year XXX -XXXX%
CreatorRank: undefined #
Social Influence #
Social category influence stocks XXXX% finance XXXX% countries XXXX%
Social topic influence $cdxs #1, $irwd #2, $lly #115, $bmy 2.04%, $15b 2.04%, $prqr 2.04%, $acet 2.04%, $fate 2.04%, $ipsc 2.04%, $abbv XXXX%
Top accounts mentioned or mentioned by @jfais20 @biohazard3737 @biochemyst1 @richtrades100 @sagimet @immunitybio @beonemedicines @iovancebio @bristolmyers @jazzpharma @servierpharma @genetech @shikhajainmd @dredkim @pikacapital @oneiltrader @bigpharmaguy @sanctuarybio @krtlarson @anonym64382296
Top assets mentioned Eli Lilly and Company (LLY) Bristol-Myers Squibb Co (BMY) AbbVie Inc (ABBV) Amicus Therapeutics, Inc (FOLD) Alnylam Pharmaceuticals, Inc. (ALNY) Novartis AG (NVS)
Top Social Posts #
Top posts by engagements in the last XX hours
"$cdxs focus with ligation is on after phase X or earlier clinical assets with full enzymatic - on preclinical ones. Some people still say they will produce inclisiran for NVS. Nonsense. NVS and ALNY secured their current siRNA manufacturing needs already"
X Link @ValueForAll1 2025-10-04T14:13Z XXX followers, XXX engagements
"If $bmy picks up preclinical Orbital for $1.5B in cash I don't see why $lly has to pay less for $prqr. Novel modalities should be valued appropriately"
X Link @ValueForAll1 2025-10-11T15:46Z XXX followers, XXX engagements
"$cdxs Finally waking up a bit. TIDES EU is in a month this webinar with Bachem looks interesting. Bachem is a one stop to $lly who are betting a lot on oligos for the upcoming decade"
X Link @ValueForAll1 2025-10-07T03:49Z XXX followers, 1192 engagements
"$acet data this week is another signal that CAR-T in I&I is not if but when. Safety will be important of course. But COGS and manufacturing time will be super important. $fate and $ipsc are the best equipped to win on COGS. Fate is on a run Century is a sleeper"
X Link @ValueForAll1 2025-10-08T21:33Z XXX followers, XXX engagements
"$irwd Very likely it's the last month below $X. ACG presentations Abbvie Q3 earnings. Maybe something bigger"
X Link @ValueForAll1 2025-10-08T21:41Z XXX followers, XXX engagements
"$bcrx deal reminds me a bit of $irwd buy of VectivBio. Bet on phase X asset but no CVR used all upfront. And fat debt to finance all that. This ended up badly for $irwd. Not sure how this plays out for BCRX. I prefer $fold approach - pay a small option fee for flipping ph3 card"
X Link @ValueForAll1 2025-10-14T11:42Z XXX followers, 2365 engagements
"As of today the vast majority of building blocks (NQP) for siRNA drugs of e.g. $alny and $nvs is manufactured using hash chemicals with a lot of toxic waste primary in China and India. There should be a better way rooting for $cdxs"
X Link @ValueForAll1 2025-09-27T23:50Z XXX followers, XXX engagements
"$irwd touched SMA200 today for the first time since forever"
X Link @ValueForAll1 2025-10-02T17:26Z XXX followers, 1176 engagements
"$tecx On April X 2025 Mcguire (BoD chair) sold 500k shares at $XXXX. The same day GOAT Timothy Springer bought 500k shares at $17.1"
X Link @ValueForAll1 2025-10-15T13:52Z XXX followers, XXX engagements